{"title":"Construction of New MRI Contrast Agents for Spatiotemporal Visualization of Nitric Oxide in Ischemia/Reperfusion Organs.","authors":"Libang Zhang, Yuze Sun, Zonglu Gao, Lin Wang, Mei Jing, Zhengsheng Yan, Anning Xu, Xun Yuan, Yihua Zhang, Jianbing Wu, Jian Zhang, Zhiqi Yin, Zhangjian Huang","doi":"10.1021/acs.jmedchem.4c01813","DOIUrl":null,"url":null,"abstract":"<p><p>Noninvasive and real-time nitric oxide (NO) visualization <i>in vivo</i> is still a challenge. Herein, we constructed a series of NO-responsive magnetic resonance imaging (MRI) contrast agents <b>Gd1b</b>-<b>e</b> by modifying Gd-DO3A using a bis-pyridyl-ethylamine side chain as a signal-amplifying moiety and <i>o</i>-phenylenediamine as a NO-responsive linker. It was found that <b>Gd1b</b>, <b>d</b>, and <b>e</b> can form macromolecular ternary complexes (Gd-Zn<sup>2+</sup>-HSA) with high longitudinal relaxivity (<i>r</i><sub>1</sub>) (12.2-16.2 mM<sup>-1</sup> s<sup>-1</sup>). Once reacting with NO, the <i>o</i>-phenylenediamine linker was hydrolyzed to produce a small molecular Gd complex with sharply decreased <i>r</i><sub>1</sub> (4.7-6.3 mM<sup>-1</sup> s<sup>-1</sup>). Among them, <b>Gd1d</b> with a desirable pharmacokinetic profile (<i>t</i><sub>1/2</sub> = 5.91 h) could clearly distinguish the ischemia-reperfusion (IR) liver with excessive NO in rats. Meanwhile, the temporarily reduced amount of NO in the IR liver and brain by the NO scavenger 2-phenyl-4,4,5,5-tetramethylimidazoline-3-oxide-1-oxyl could enhance the signal of <b>Gd1d</b>, suggesting anticipated NO-responsive property. This research offers a new avenue for insight into the NO spatiotemporal property in multiple IR organs.</p>","PeriodicalId":46,"journal":{"name":"Journal of Medicinal Chemistry","volume":" ","pages":"18512-18525"},"PeriodicalIF":6.8000,"publicationDate":"2024-10-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Medicinal Chemistry","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1021/acs.jmedchem.4c01813","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/10/4 0:00:00","PubModel":"Epub","JCR":"Q1","JCRName":"CHEMISTRY, MEDICINAL","Score":null,"Total":0}
引用次数: 0
Abstract
Noninvasive and real-time nitric oxide (NO) visualization in vivo is still a challenge. Herein, we constructed a series of NO-responsive magnetic resonance imaging (MRI) contrast agents Gd1b-e by modifying Gd-DO3A using a bis-pyridyl-ethylamine side chain as a signal-amplifying moiety and o-phenylenediamine as a NO-responsive linker. It was found that Gd1b, d, and e can form macromolecular ternary complexes (Gd-Zn2+-HSA) with high longitudinal relaxivity (r1) (12.2-16.2 mM-1 s-1). Once reacting with NO, the o-phenylenediamine linker was hydrolyzed to produce a small molecular Gd complex with sharply decreased r1 (4.7-6.3 mM-1 s-1). Among them, Gd1d with a desirable pharmacokinetic profile (t1/2 = 5.91 h) could clearly distinguish the ischemia-reperfusion (IR) liver with excessive NO in rats. Meanwhile, the temporarily reduced amount of NO in the IR liver and brain by the NO scavenger 2-phenyl-4,4,5,5-tetramethylimidazoline-3-oxide-1-oxyl could enhance the signal of Gd1d, suggesting anticipated NO-responsive property. This research offers a new avenue for insight into the NO spatiotemporal property in multiple IR organs.
期刊介绍:
The Journal of Medicinal Chemistry is a prestigious biweekly peer-reviewed publication that focuses on the multifaceted field of medicinal chemistry. Since its inception in 1959 as the Journal of Medicinal and Pharmaceutical Chemistry, it has evolved to become a cornerstone in the dissemination of research findings related to the design, synthesis, and development of therapeutic agents.
The Journal of Medicinal Chemistry is recognized for its significant impact in the scientific community, as evidenced by its 2022 impact factor of 7.3. This metric reflects the journal's influence and the importance of its content in shaping the future of drug discovery and development. The journal serves as a vital resource for chemists, pharmacologists, and other researchers interested in the molecular mechanisms of drug action and the optimization of therapeutic compounds.